Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging



Status:Recruiting
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:10/29/2017
Start Date:April 2016
End Date:August 2018
Contact:Eyal Oren, PhD
Email:eoren@email.arizona.edu
Phone:(520) 626-7008

Use our guide to learn which trials are right for you!

Promoting Adherence to Treatment for Latent TB Infection Through Mobile Phone Text Messaging

The purpose of this pilot study is to determine whether regularly scheduled medication
reminder text messages (SMS) are effective in increasing latent tuberculosis infection (LTBI)
treatment completion.

We aim to determine the feasibility and acceptability of text reminders for improving
adherence in latent TB patients. Specific objectives of the current study are to: 1) Assess
the feasibility of the intervention as indicated by participant recruitment and retention
and; 2) Evaluate the acceptability of the intervention, as indicated by intervention
adherence, outcome measurement rates, and feedback from participants.

Data will be used to design a definitive trial which will test the hypothesis that the
intervention will improve medication adherence, as measured through an increase in treatment
completion rates, and result in higher self-reported medication adherence, fewer missed
appointments and doses, and a shorter course of treatment.

Inclusion Criteria:

- Consent to the study

- Own a mobile phone which operates on a telecom provider supported by our SMS platform

- Initiating or actively receiving treatment for LTBI at the Pima County TB Clinic in
Tucson, AZ

- Prescribed self-administered therapy

- Report not having prior or current active TB disease

- Know how to and are able to receive SMS messages

- At least 18 years of age

Exclusion Criteria:

- Do not meet inclusion criteria

- Do not consent to study
We found this trial at
1
site
Tucson, Arizona 85714
?
mi
from
Tucson, AZ
Click here to add this to my saved trials